A new perspective on special effective interventions for metabolic syndrome risk factors: a systematic review and meta-analysis

Abstract

Metabolic syndrome (MetS) has the largest global burden of all noncommunicable diseases. Owing to the clinical heterogeneity of MetS, wide variations have been reported in the efficacy of moderate-to-vigorous physical activity (MVPA) and intermittent fasting (IF) for improving MetS. We searched five databases for randomized controlled trials published through December 2021, and 372 participants from 11 studies were included in this meta-analysis. Compared with MVPA alone, IF combined with MVPA had a more significant effect on improving body mass and levels of fasting blood glucose and high-density lipoprotein cholesterol; however, it was ineffective in improving triglycerides level, systolic blood pressure, and diastolic blood pressure. Subgroup analysis showed that, except for blood pressure, time-restricted fasting combined with MVPA had a better effect than alternate-day fasting with MVPA. Meanwhile, when the intervention lasted longer than 8 weeks, the effect of the combined intervention was significantly better than that of MVPA alone. This finding provides a basis for clinicians to manage the health of overweight individuals. This study also showed that Caucasians may be more suitable for the combined intervention than Asians. And the combined intervention may provide a preventive effect for MetS risk factors in healthy populations, although this may be due to the small sample size. In general, this study provides a novel perspective on special interventions for MetS traits.

Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?

“…Metabolic syndrome, described by Reaven in 1988 [1], has been considered the disease of the century, with increasing prevalence rates worldwide that have reached 40% in some countries [2,3]. Closely related to obesity and diabetes mellitus (DM), the condition comprises a set of associated metabolic changes, such as hyperglycemia, dyslipidemia, insulin resistance, arterial hypertension, and visceral obesity, resulting in a pro-thrombotic and pro-inflammatory state accompanied by an increase in some cytokines and C-reactive protein (CRP) [4,5]. The chronic inflammatory state of patients with metabolic syndrome has been postulated to increase vulnerability to pro-inflammatory triggers of viral infections, which can worsen the outcomes of diseases caused by influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [6].…”

Moderate or greater daily coffee consumption is associated with lower incidence of metabolic syndrome in Taiwanese militaries: results from the CHIEF cohort study

“…Metabolic syndrome (MetS) represents a combination of cardiovascular risk factors, including insulin resistance, dyslipidemia, obesity, and hypertension. Despite variations in its definition, MetS is estimated to affect approximately a quarter of the global population and has the largest global burden of all non-communicable diseases ( 1 , 2 ). Over the past three decades, the prevalence of MetS in the United States has surged by nearly 30% ( 3 ).…”

Effects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease

“…In Ukraine, the statistical registration of GERD began in 2009, and, unfortunately, finished in 2017, so there were the latest data on the prevalence of GERD. However, there are isolated reports that GERD prevalence in Ukraine ranges from 7.6 to 23.9 % [3]. Among the well-known factors contributing to an increase in the prevalence of GERD, a growing number of overweight and obese people is of particular importance [4,5].…”